Vantiv, Inc. (NYSE:VNTV) Cut to "Hold" at BidaskClub

Vantiv, Inc. (NYSE:VNTV) Cut to

A number of other brokerages also recently weighed in on VNTV. KeyCorp lowered shares of Vantiv to a "hold" rating in a report on Monday, June 12th.

On August 11 Citigroup kept the company rating at "Buy" but moved up the price target from $46.50 to $74.00. Zacks Investment Research raised shares of Vantiv from a "hold" rating to a "buy" rating and set a $73.00 price target for the company in a report on Tuesday, April 25th.

Among 22 analysts covering CVS Health (NYSE:CVS), 13 have Buy rating, 0 Sell and 9 Hold. The stock's average target of $64.48 is -10.48% below today's ($72.03) share price.

Freeport-McMoran (FCX) Given Daily Media Impact Rating of 0.22
Freeport-McMoRan Inc. (FCX) has been given an average price target of $14.76 from analysts, according to data collected by Finviz. On average, equities research analysts anticipate that Freeport-McMoran will post $0.89 EPS for the current fiscal year.

Vantiv, Inc. (NYSE:VNTV)'s latest quote $70.45 $0.32 0.6% will find technical support in $69.83 a share and a breakdown below this region would be a significantly bearish signal for Vantiv, Inc. traders. The overall volume in the last trading session was 3.25 million shares. It is positive, as 31 investors sold Vantiv Inc shares while 131 reduced holdings. Using a bigger time frame to assess the moving average such as the 200-day, may help block out the noise and chaos that is often caused by daily price fluctuations. The company has a market capitalization of $11.59 billion, a price-to-earnings ratio of 60.74 and a beta of 0.61. More interesting news about Vantiv Inc (NYSE:VNTV) were released by: and their article: "Vantiv Added To Stifel's "Select List" Following WorldPay Acquisition" published on August 10, 2017 as well as's news article titled: "Vantiv Announces Date Change for Second Quarter 2017 Financial Results" with publication date: August 08, 2017. The business services provider reported $0.83 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.82 by $0.01. During the same period in the prior year, the firm posted $0.70 earnings per share. Over the last week of the month, it was 10.44%, 15.37% over the last quarter, and 11.90% for the past six months.

Vantiv (NYSE VNTV) transacted up 0.60% throughout intraday market trading on early Friday, topping $70.45. If you are accessing this piece on another site, it was copied illegally and republished in violation of United States and worldwide copyright and trademark law. The legal version of this piece of content can be accessed at The shares were sold on June 9th for an average price of $63.40. The Waverton Investment Management Ltd holds 53,287 shares with $4.21M value, down from 134,983 last quarter. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Institutional investors own 82.85% of the company's stock. Great Lakes Advisors LLC boosted its stake in shares of Vantiv by 1.5% in the second quarter. Telemus Capital has an ownership of 12,092 stocks of the firm services provider's shares valued at $775,000 after scooping up an extra 92 shares through out the previous quarter, Lastly, Wedge Capital Management L L P NC boosted its stake in stocks of Vantiv by 0.8% in the Fiscal Q2. Teachers Advisors LLC boosted its stake in Vantiv by 2.4% in the fourth quarter. BlackRock Inc. raised its stake in Vantiv by 3,456.0% in the first quarter. The Tiaa Cref Investment Management Llc holds 559,896 shares with $33.38 million value, down from 633,651 last quarter. Diamond Hill Capital Management Inc. now owns 4,404,876 shares of the business services provider's stock worth $279,005,000 after buying an additional 235,112 shares during the period. Diamond Hill Capital Management Inc. increased its stake in Vantiv by 5.6% in the second quarter. Investec Asset Management LTD now owns 3,645,303 shares of the business services provider's stock valued at $230,893,000 after buying an additional 128,308 shares in the last quarter. A P/B ratio of less than 1.0 can indicate that a stock is undervalued, while a ratio of greater than 1.0 may indicate that a stock is overvalued.

According to Financial Times, The 2 analysts offering 12 month price targets for Synthetic Biologics Inc have a median target of 3.25, with a high estimate of 3.50 and a low estimate of 3.00. The Firm conducts its activities through its subsidiary, Vantiv Holding, LLC. The Firm is a payment processor. The Company's divisions include Merchant Services and Financial Institution Services.